Chieko Hamada

Chieko Hamada

Auto-generated profile, based on publicly available information

Chieko Hamada

Juntendo University

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2015 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
CHChieko Hamada
Chieko Hamada
KHKazuho Honda
Kazuho Honda
KKKunio Kawanishi
Kunio Kawanishi
HNHirotaka Nakamoto
Hirotaka Nakamoto
YIYasuhiko Ito
Yasuhiko Ito
MNMasaaki Nakayama
Masaaki Nakayama

6 February 2014 in Journal Of Nephrology
Verified
Journal Article
Open access
PDF file
TSTakuya Seto
Takuya Seto
CHChieko Hamada
Chieko Hamada
YTYasuhiko Tomino
Yasuhiko Tomino
Background Medial vascular calcification is a specific complication in chronic kidney disease (CKD) patients although its pathogenesis is poorly understood. The administration of iron (Fe), generally used for the treatment of anemia in CKD patients, induces oxidative stress. Fe loading possibly affects the progress of vascular calcification in uremia. We investigated the effect of Fe on vascular calcification and its mechanism in uremic rats. Method Thirty-two rats were divided into four groups: untreated rats (controls), rats fed a standard diet with Fe administration (Fe group), rats fed an adenine-enriched diet (uremic group), and rats fed an adenine-enriched diet with Fe administration (uremic + Fe group). Iron dextran was administered once a week for 5 weeks intraperitoneally. Morphological alterations and vascular calcification-associated factors in the aortic wall were evaluated. Results No aortic calcification was observed in the control group although uremic rats developed severe vascular calcification. Fe loading suppressed vascular calcification in the uremic groups. Expressions of runt-related transcription factor 2 (Runx2), single-strand (ss)DNA and phosphate transporter (Pit)-1 were increased in the uremic rats compared to the control rats. In the uremic group, Fe administration did not show any effect on ssDNA expression, but reduced Runx2 and Pit-1 expressions. Conclusion Fe suppressed the development of vascular calcification through the prevention of Pit-1 and vascular smooth muscle cell osteoblastic transdifferentiation.

19 September 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKazuaki Hara
Kazuaki Hara
CHChieko Hamada
Chieko Hamada
KWKeiichi Wakabayashi
Keiichi Wakabayashi
RKReo Kanda
Reo Kanda
KKKayo Kaneko
Kayo Kaneko
YSYusuke Suzuki
Yusuke Suzuki
High glucose concentrations influence the functional and structural development of the peritoneal membrane. We previously reported that the oral administration of astaxanthin (AST) suppressed peritoneal fibrosis (PF) as well as inhibited oxidative stress, inflammation, and epithelial–mesenchymal transition (EMT) of peritoneal mesothelial cells (PMCs) in a chlorhexidine-induced PF rat model. This suggests that oxidative stress induction of EMT is a key event during peritoneal damage. The present study evaluated the therapeutic effect of AST in suppressing EMT, in response to glucose-induced oxidative stress. Temperature-sensitive mesothelial cells (TSMCs) were cultured in the presence or absence of AST and then treated with 140 mM glucose for 3 or 12 hours. Expression levels of TNF-α, TGF-β, and VEGF were determined at the mRNA and protein levels, and nuclear factor kappa B (NF-κB) activity was evaluated. We measured NO2−/NO3− concentrations in cellular supernatants and determined 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels in mitochondrial and nuclear DNA. The expressions of E-cadherin and alpha-smooth muscle actin (α-SMA) were evaluated by double immunofluorescence and protein levels. High glucose concentrations induced overproduction of reactive oxidative species (ROS), increasing 8-OHdG mitochondrial DNA and cytokine levels. The NF-κB pathway was activated in response to high glucose concentrations, whereas de novo α-SMA expression was observed with decreased E-cadherin expression. AST treatment attenuated ROS production, inflammatory cytokine production, NF-κB activation, and EMT. The findings of the present study indicate that AST may have an anti-EMT effect due to anti-oxidative and anti-inflammatory activities by scavenging glucose-induced ROS from mitochondria in PMCs. AST may be an efficacious treatment for PF.

6 June 2023 in Clinical and Experimental Nephrology
Verified
Journal Article
Open access
PDF file
MNMasaaki Nakayama
Masaaki Nakayama
MMMasanobu Miyazaki
Masanobu Miyazaki
CHChieko Hamada
Chieko Hamada
YIYasuhiko Ito
Yasuhiko Ito
KHKazuho Honda
Kazuho Honda
Encapsulating peritoneal sclerosis (EPS), a condition with a high mortality rate, is a serious complication of peritoneal dialysis (PD). In Japan, EPS became a central issue in the clinical setting during the mid-90s and the beginning of this century. However, following the introduction of biocompatible neutral PD solutions containing lower levels of glucose degradation products, the incidence and clinical severity of EPS has been greatly lessened. During the past three decades, the etiology of EPS has been elucidated by findings obtained by peritoneal biopsy, laparoscopy, and surgical intervention. Accumulating findings suggest the need for a paradigm change on the nature of EPS pathophysiology; notably, EPS appears not to reflect peritoneal sclerosis per se, but rather the formation of a neo-membrane as a biological reaction to peritoneal injury. This narrative review looks back on the history of EPS in Japan, and discusses EPS pathophysiology, the impact of neutral PD solution on peritoneal protection, and a future novel diagnostic approach, ultra-fine endoscope, for the identification of patients at high risk of EPS.

14 December 2013 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
HNHirotaka Nakamoto
Hirotaka Nakamoto
CHChieko Hamada
Chieko Hamada
TSTetsutaro Shimaoka
Tetsutaro Shimaoka
YSYoshimi Sekiguchi
Yoshimi Sekiguchi
HIHiroaki Io
Hiroaki Io
YTYasuhiko Tomino
Yasuhiko Tomino

27 September 2012 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
RKReo Kanda
Reo Kanda
CHChieko Hamada
Chieko Hamada
KKKayo Kaneko
Kayo Kaneko
TNTakanori Nakano
Takanori Nakano
KWKeiichi Wakabayashi
Keiichi Wakabayashi
YTYasuhiko Tomino
Yasuhiko Tomino